tm logo

Monitor this mark

View On USPTO

SYMBIOCELLTECH
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 24 Jan 2024

Last Applicant/ Owned by

SymbioCell Tech, LLC

615 Arapeen Drive, Suite 210

Salt Lake City

UT

84108

Serial Number

87320843 filed on 01st Feb 2017

Registration Number

5525659 registered on 24th Jul 2018

in the Principal Register

Correspondent Address

James C. Watson

James C. Watson

230 SOUTH 500 EAST, #300

SALT LAKE CITY,UT 84102

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SYMBIOCELLTECH

Cell-based therapeutic preparations for diabetes, neurodegenerative diseases, muscular dystrophy and autoimmune endocrine disorders

Classification Information

Class [005]
Pharmaceutical Products

Cell-based therapeutic preparations for diabetes, neurodegenerative diseases, muscular dystrophy and autoimmune endocrine disorders

First Use Date in General

30th May 2017

First Use Date in Commerce

30th May 2017

Specimens

SYMBIOCELLTECH specimenSYMBIOCELLTECH specimen

Mark Details

Serial Number

No 87320843

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 285-TM3314US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
24th Jan 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24th Jan 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24th Jan 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01st Aug 2023TEAS SECTION 8 & 15 RECEIVED
24th Jul 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
24th Jul 2018REGISTERED-PRINCIPAL REGISTER
19th Jun 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
18th Jun 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13th Jun 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
13th Jun 2018STATEMENT OF USE PROCESSING COMPLETE